No Detail Found!

Protective Effects of Mefenamic Acid against Pentylenetetrazol- Induced Seizures: An Experimental Study

Author(s)
Sayyed Mudasar Hussain Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Ziauddin University Karachi, Pakistan
Uzair Nisar Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Ziauddin University Karachi, Pakistan
Kalpana Jeewnani Department of Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences, Ziauddin University Karachi, Pakistan
Muhammad Jamal Department of Pharmacy, City University of Science and Information Technology,Peshawar,Pakistan
Shabana Usman Simjee H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi,Karachi-75270,Pakistan
Umbreen Farrukh Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Dow College of Pharmacy, Dow University of Health Sciences,Karachi,Pakistan
Abstract
Background: Epilepsy is a chronic neurological disorder characterized by recurrent seizures due to abnormal electrical activity in the brain. Despite advancements in treatment, approximately 30% of patients remain unresponsive to current antiepileptic drugs (AEDs), highlighting the need for alternative therapies. Mefenamic acid (MFA), a nonsteroidal anti-inflammatory drug (NSAID), has shown potential anticonvulsant properties, possibly through modulation of GABAA receptors and adenosine signaling. Objective: This study aimed to evaluate the anticonvulsant effects of MFA in a pentylenetetrazol (PTZ)-induced seizure model in mice, focusing on its possible mechanisms of action. Methods: Male NMRI mice were administered MFA at doses of 5, 10, and 15 mg/kg i.p40 minutes before PTZ (80 mg/kg i.p.) to induce seizures. Diazepam served as a standard drug, and caffeine was used to investigate adenosine receptor modulation. Seizure onset, duration, and severity were recorded. Data were analyzed using one-way ANOVA followed by Tukey's post-hoc test. Results: MFA at 5 mg/kg significantly delayed seizure onset and provided complete protection against PTZ-induced seizures, with results comparable to diazepam. Higher doses (10 and 15 mg/kg) delayed seizure latency but were less effective in reducing seizure duration. The addition of caffeine nullified MFA's protective effects, suggesting adenosine A1 receptor involvement. Conclusion: MFA, particularly at 5 mg/kg, exhibits significant anticonvulsant effects in a PTZ-induced seizure model, likely through GABAergic modulation and adenosine A1 receptor interaction. These findings suggest MFA as a potential adjunctive therapy for epilepsy, warranting further investigation.
Publication Details
Page(s) 67-74
DOI DOI not available
Published Journal: RADS Journal of Pharmacy and Allied Health Sciences, Volume: 2, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Epilepsy, Anticonvulsant, Mefenamic Acid, Pentylenetetrazol, Neuroinflammation, GABAA Receptors, Adenosine A1 Receptor
References
Bankole NDA,Dokponou YCH,De Koning R,Dalle DU,Kesici Ö,Egu C .2024 .Epilepsy care and outcome in low-and middle-income countries: A scoping review. Journal of Neurosciences in Rural Practice, 15(1) : 8.
Chen Z,Brodie MJ,Liew D,Kwan P .2018 .Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA neurology, 75(3) : 279-86.
Abdulrahman KAB,Alharbi MG,Alzeer AM .2022 .Awareness and attitudes toward epilepsy among medical students and interns in Riyadh, Saudi Arabia. Primary Health Care Research & Development, 23 : e70.
Treiman DM .2001 .GABAergic mechanisms in epilepsy. Epilepsia, 42 : 8-12.
Alomar S,Kadi M,Alabbas D,Aljeddawi M,Alsulaiman S,Baeesa S .2020 .Awareness and attitudes toward epilepsy among medical and allied healthcare students-a survey study in a teaching hospital in Jeddah. Epilepsy & Behavior, 102 : 106815.
Aguiar CCT,Almeida AB,Araújo PVP,Abreu RNDCd,Chaves EMC,Vale OCd .2012 .Oxidative stress and epilepsy: literature review. Oxidative medicine and cellular longevity, : 795259.
Devinsky O,Vezzani A,Najjar S,De Lanerolle NC,Rogawski MA .2013 .Glia and epilepsy: excitability and inflammation. , 36(3) : 174-84.
Rana A,Musto AE .2018 .The role of inflammation in the development of epilepsy. Journal of neuroinflammation, 15 : 1-12.
Ghosh S,Sinha JK,Ghosh S,Sharma H,Bhaskar R,Narayanan KB .2023 .A comprehensive review of emerging trends and innovative therapies in epilepsy management. Brain Sciences, 13(9) : 1305.
Shea JM,Villeda SA .2024 .Microglia aging in the hippocampus advances through intermediate states that drive inflammatory activation and cognitive decline. bioRxiv, : .
Riva A,Golda A,Balagura G,Amadori E,Vari MS,Piccolo G .2021 .New trends and most promising therapeutic strategies for epilepsy treatment. , 12 : 753753.
Thijs RD,Surges R,O'Brien TJ,Sander JW .2019 .Epilepsy in adults. The lancet. , 393(10172) : 689-701.
Vezzani A,Aronica E,Mazarati A,Pittman QJ .2013 .Epilepsy and brain inflammation. Experimental neurology, 244 : 11-21.
Zhao L,Li L,Ma L,Wang Y,Li J,Shi W-Y .2016 .NSAIDs modulate GABA-activated currents via Ca2+-activated Cl− channels in rat dorsal root ganglion neurons. Experimental and Therapeutic Medicine, 11(5) : 1755-61.
Khansari PS .2012 .NSAIDs in the treatment and/or prevention of neurological disorders. Inflammopharmacology, 20(3) : 159-67.
Halliwell RF,Thomas P,Patten D,James C,Martinez‐Torres A,Miledi R .1999 .Subunitselective modulation of GABAA receptors by the non‐steroidal anti‐inflammatory agent, mefenamic acid. European Journal of Neuroscience, 11(8) : 2897-905.
Löscher W,White HS .2023 .Animal models of drugresistant epilepsy as tools for deciphering the cellular and molecular mechanisms of pharmacoresistance and discovering more effective treatments. Cells, 12(9) : 1233.
Davis SF,Linn CL .2003 .Activation of NMDA receptors linked to modulation of voltagegated ion channels and functional implications. American Journal of Physiology-Cell Physiology, 284(3) : C757-C68.
Shimada T,Takemiya T,Sugiura H,Yamagata K. .2014 .Role of inflammatory mediators in the pathogenesis of epilepsy. Mediators of inflammation, : 901902.
Löscher W,Klitgaard H,Twyman RE,Schmidt D .2013 .New avenues for anti-epileptic drug discovery and development. Nature reviews drug discovery, 12(10) : 757-76.
Alachkar A,Ojha SK,Sadeq A,Adem A,Frank A,Stark H .2020 .Experimental models for the discovery of novel anticonvulsant drugs: focus on pentylenetetrazole-induced seizures and associated memory deficits. Current pharmaceutical design, 26(15) : 1693-711.
Foiadelli T,Santangelo A,Costagliola G,Costa E,Scacciati M,Riva A .2023 .Neuroinflammation and status epilepticus: a narrative review unraveling a complex interplay. Frontiers in Pediatrics, 11 : 1251914.
Vezzani A,Friedman A,Dingledine RJ .2013 .The role of inflammation in epileptogenesis. Neuropharmacology, 69 : 16-24.
Shabbir A,Arshad HM,Shahzad M,Shamsi S,Ashraf MI .2016 .Immunomodulatory activity of mefenamic acid in mice models of cellmediated and humoral immunity. Indian Journal of Pharmacology, 48(2) : 172-8.
Ghosh S,Sinha JK,Khan T,Devaraju KS,Singh P,Vaibhav K .2021 .Pharmacological and therapeutic approaches in the treatment of epilepsy. Biomedicines, 9(5) : 470.
Salmanzadeh H,Halliwell RF .2024 .Antiseizure properties of fenamate NSAIDs determined in mature human stem-cell derived neuroglial circuits. Frontiers in Pharmacology, 15 : 1385523.
Ribeiro JA,Sebastiao AM .2010 .Caffeine and adenosine. Journal of Alzheimer's disease, 20(s1) : S3-S15.
Sanz P,Rubio T,Garcia-Gimeno MA .2024 .Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs. International Journal of Molecular Sciences, 25(8) : 4161.
Tescarollo FC,Rombo DM,DeLiberto LK,Fedele DE,Alharfoush E,Tomé ÂR .2020 .Role of adenosine in epilepsy and seizures. Journal of caffeine and adenosine research, 10(2) : 45-60.
Spanoghe J,Larsen LE,Craey E,Manzella S,Van Dycke A,Boon P .2020 .The signaling pathways involved in the anticonvulsive effects of the adenosine A1 receptor. International journal of molecular sciences, 22(1) : 320.
Feng X,Fan Y,Chung CY .2020 .Mefenamic acid can attenuate depressive symptoms by suppressing microglia activation induced upon chronic stress. Brain research, 1740 : 146846.
Masri A,Khan NA,Zoqratt MZHM,Ayub Q,Anwar A,Rao K .2021 .Transcriptome analysis of Escherichia coli K1 after therapy with hesperidin conjugated with silver nanoparticles. BMC microbiology, 21 : 1-11.
Sumadewi KT,Harkitasari S,Tjandra DC .2023 .Biomolecular mechanisms of epileptic seizures and epilepsy: a review. Acta Epileptologica, 5(1) : 28.
Cai Y,Z. Ferroptosis Y .2021 .and its role in epilepsy. Frontiers in Cellular Neuroscience, 15 : 696889.
0

Citations

0

Downloads

6

Views